Mesenchymal Stromal Cells Engineered to Express Erythropoietin Induce Anti-erythropoietin Antibodies and Anemia in Allorecipients
Open Access
- 1 February 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (2) , 369-372
- https://doi.org/10.1038/mt.2008.270
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemiaAmerican Journal of Physiology-Renal Physiology, 2008
- Epoetin‐associated pure red cell aplasia: past, present, and future considerationsTransfusion, 2008
- Generation of a Transplantable Erythropoietin-Producer Derived From Human Mesenchymal Stem CellsTransplantation, 2008
- Design and Fabrication of 3D Porous Scaffolds to Facilitate Cell-Based Gene TherapyTissue Engineering, Part A, 2008
- Progress Toward A Nonviral Gene Therapy Protocol for The Treatment of AnemiaHuman Gene Therapy, 2007
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005
- Autoimmune anemia in macaques following erythropoietin gene therapyBlood, 2004
- Erythropoietin gene therapy leads to autoimmune anemia in macaquesBlood, 2004
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsPublished by Elsevier ,2003
- Induction of T H 1 and T H 2 Immunity in Neonatal MiceScience, 1996